Wall Street earnings season for Q4 2023 has been on for around a month already. Majority of US large-cap companies have already reported their results. However, the earnings season for small caps is far from over, with less than 30% of Russell 2000 stocks having already reported.
How many US companies already reported results?
- S&P 500 (US500): 334 out of 500 companies (around 67%)
- Dow Jones (US30): 25 out of 30 companies (around 83%)
- Nasdaq-100 (US100): 57 out of 100 companies (57%)
- Russell 2000 (US2000): 554 out of 1944 companies (around 28%)
Having said that, earnings calendar in the coming weeks will be increasingly dominated by smaller, lesser-known stocks. Nevertheless, investors will still be offered reports from some larger and better-known companies. Among this week's highlights, one can find Arista Networks (Monday), Coca-Cola (Tuesday), Robinhood Markets (Tuesday), Barrick Gold (Wednesday) and Coinbase (Thursday).
Top Wall Street earnings scheduled for this week. Source: Bloomberg Finance LP, XTB Research
US Open: Hope for De-escalation Bolsters Wall Street Bulls
Apple earnings beat Wall Street estimates 🚨 iPhone sales below expectations
🗽S&P 500 companies with the record net margin since 2009 - FactSet data
Market Wrap: UK100 skyrockets after BoE 🇬🇧 🚀 Euphoric gain as ECB Lagarde speaks 🇪🇺 📈
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
